Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4

Bioorg Med Chem Lett. 2007 Nov 1;17(21):5897-901. doi: 10.1016/j.bmcl.2007.07.105. Epub 2007 Aug 26.

Abstract

Fourteen N-acetylated and non-acetylated 3,4,5-tri- or 2,5-dimethoxypyrazoline analogs of combretastatin-A4 (1) were synthesized. A non-acetylated derivative (5a) with the same substituents as CA-4 (1) was the most active compound in the series, with IC(50) values of 2.1 and 0.5 microM in B16 and L1210 cell lines, respectively. In contrast, a similar compound with an acetyl group at N1 of the pyrazoline ring (6g) showed poor activity in the cell lines studied. A cell-based assay indicated that compound 5a caused extensive microtubule depolymerization with an EC(50) value of 7.1 microM in A-10 cells while no activity was seen with the acetylated compound. Molecular modeling studies showed that these compounds possess a twisted conformation similar to CA-4 (1).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Drug Design*
  • Mice
  • Models, Molecular
  • Pyrazoles / chemistry*
  • Stilbenes / chemical synthesis
  • Stilbenes / chemistry*
  • Stilbenes / pharmacology*

Substances

  • Pyrazoles
  • Stilbenes
  • fosbretabulin